Table 3.
Clinical and Functional Outcomesa
No. of Studies | No. of Patients | MD/RR (95% CI) | P Value | |
---|---|---|---|---|
IKDC | ||||
Absolute scoreb | 4 | 287 | –2.18 (–4.29 to –0.07) | .04 |
Improvementc | 4 | 287 | 0.20 (–2.65 to 3.05) | .89 |
Lysholm | ||||
Absolute scoreb | 4 | 287 | –1.87 (–3.90 to 0.15) | .07 |
Improvementc | 4 | 287 | –1.98 (–6.93 to 2.98) | .43 |
Tegner | ||||
Absolute scoreb | 2 | 157 | –0.53 (–1.09 to 0.04) | .07 |
Improvementc | 2 | 157 | –0.10 (–0.69 to 0.49) | .75 |
Knee AP stability | 3 | 202 | 0.73 (0.23 to 2.34) | .59 |
aAP, anteroposterior; IKDC, International Knee Documentation Committee; MD, mean difference; RR, risk ratio.
bAt 1 to 2 years after index surgery.
cDifference between the last follow-up and baseline.